Table 3.
Total testosterone (ng/dL) | p | Free testosterone (ng/dL) | p | Bioavailable testosterone (ng/dL) | p | |
---|---|---|---|---|---|---|
High risk cancer | 347±128 | 0.443 | 6.1±2 | 0.001 | 148±48 | 0.0001 |
Benign, low and intermediate risk | 328±124 | 5.2±1.6 | 124±43 |
Total testosterone (ng/dL) | p | Free testosterone (ng/dL) | p | Bioavailable testosterone (ng/dL) | p | |
---|---|---|---|---|---|---|
High risk cancer | 347±128 | 0.443 | 6.1±2 | 0.001 | 148±48 | 0.0001 |
Benign, low and intermediate risk | 328±124 | 5.2±1.6 | 124±43 |